Hilmi Özçelik

7.3k total citations · 1 hit paper
79 papers, 3.6k citations indexed

About

Hilmi Özçelik is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hilmi Özçelik has authored 79 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 34 papers in Genetics and 17 papers in Oncology. Recurrent topics in Hilmi Özçelik's work include BRCA gene mutations in cancer (23 papers), DNA Repair Mechanisms (11 papers) and CRISPR and Genetic Engineering (11 papers). Hilmi Özçelik is often cited by papers focused on BRCA gene mutations in cancer (23 papers), DNA Repair Mechanisms (11 papers) and CRISPR and Genetic Engineering (11 papers). Hilmi Özçelik collaborates with scholars based in Canada, United States and Australia. Hilmi Özçelik's co-authors include Irene L. Andrulis, Bharati Bapat, Sevtap Savas, Laurent Briollais, Hamdi Jarjanazi, Jeffrey L. Wrana, Stephen W. Scherer, L.-C. Tsui, Gerald H. Thomsen and Pamela A. Hoodless and has published in prestigious journals such as Cell, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hilmi Özçelik

79 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma

1996 717 citations Hilmi Özçelik, Bharati Bapat et al. profile →

Peers

Countries citing papers authored by Hilmi Özçelik

Since Specialization

Citations

This map shows the geographic impact of Hilmi Özçelik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilmi Özçelik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilmi Özçelik more than expected).

Fields of papers citing papers by Hilmi Özçelik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilmi Özçelik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilmi Özçelik. The network helps show where Hilmi Özçelik may publish in the future.

Co-authorship network of co-authors of Hilmi Özçelik

This figure shows the co-authorship network connecting the top 25 collaborators of Hilmi Özçelik. A scholar is included among the top collaborators of Hilmi Özçelik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilmi Özçelik. Hilmi Özçelik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Bayesian graphical model for genome-wide association studies (GWAS) 2016 ·The Annals of Applied Statistics ·Laurent Briollais, Adrian Dobra, Jinnan Liu, (unknown), Hilmi Özçelik, Hélène Massam	4
2	Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis 2015 ·Journal of Gastrointestinal Cancer ·Noel Pabalan, Hamdi Jarjanazi, Hilmi Özçelik	7
3	Active Cigarette Smoking, Variants in Carcinogen Metabolism Genes and Breast Cancer Risk among Pre- and Postmenopausal Women in Ontario, Canada 2014 ·The Breast Journal ·Michelle Cotterchio, Lucia Mirea, Hilmi Özçelik, Nancy Kreiger	14
4	The Impact of Capsaicin Intake on Risk of Developing Gastric Cancers: A Meta-Analysis 2014 ·Journal of Gastrointestinal Cancer ·Noel Pabalan, Hamdi Jarjanazi, Hilmi Özçelik	27
5	A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations 2013 ·International Journal of Colorectal Disease ·Noel Pabalan, Hamdi Jarjanazi, Hilmi Özçelik	5
6	Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation Carriers 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Esther M. John, Valerie McGuire, Duncan C. Thomas, Robert W. Haile, Hilmi Özçelik, Roger L. Milne, Anna Felberg, Dee W. West, Alexander Miron, Julia A. Knight, Mary Beth Terry, Mary Daly, Saundra S. Buys, Irene L. Andrulis, John L. Hopper, Melissa C. Southey, Graham G. Giles, Carmel Apicella, Heather Thorne, Alice S. Whittemore	17
7	Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer 2012 ·Journal of Molecular Diagnostics ·Hilmi Özçelik, Xuejiang Shi, Martin C. Chang, (unknown), (unknown), Nando Di Nicola, (unknown), (unknown), Aaron Goldman, Mark Dowar, Balram Sukhu, Rita A. Kandel, Kathy Siminovitch	45
8	NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells 2011 ·PLoS ONE ·Sevtap Savas, David O. Azorsa, Hamdi Jarjanazi, Irada Ibrahim-zada, (unknown), Shilpi Arora, Meredith C. Henderson, Yun‐Hee Choi, Laurent Briollais, Hilmi Özçelik, Şükrü Tüzmen	14
9	Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer 2010 ·Breast Cancer Research and Treatment ·Noel Pabalan, (unknown), Lillian Sung, Hamdi Jarjanazi, Hilmi Özçelik	37
10	DNA methylation of HOXD3 as a marker of prostate cancer progression 2010 ·Laboratory Investigation ·Ken J. Kron, Liyang Liu, Vaijayanti Pethe, (unknown), Michael Nesbitt, John Trachtenberg, Hilmi Özçelik, Neil Fleshner, Laurent Briollais, Theodorus van der Kwast, Bharati Bapat	46
11	BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research 2008 ·Breast Cancer Research and Treatment ·(unknown), Susan L. Neuhausen, Hilmi Özçelik, Melissa C. Southey, Esther M. John, Andrew K. Godwin, Wendy K. Chung, Jeniffer Iriondo‐Perez, Alexander Miron, Regina M. Santella, Alice S. Whittemore, Irene L. Andrulis, Saundra S. Buys, Mary B. Daly, John L. Hopper, Daniela Seminara, Ruby T. Senie, Mary Beth Terry	41
12	Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis 2007 ·BMC Cancer ·Jane C. Figueiredo, Julia A. Knight, (unknown), Sevtap Savas, Venus Onay, Laurent Briollais, Pamela J. Goodwin, John McLaughlin, Irene L. Andrulis, Hilmi Özçelik	23
13	Genome Wide Screening of CAG Trinucleotide Repeat Lengths in Breast Cancer 2006 ·Disease Markers ·Hamdi Jarjanazi, Hong Li, Irene L. Andrulis, Hilmi Özçelik	2
14	SNP-SNP interactions in breast cancer susceptibility 2006 ·BMC Cancer ·Venus Onay, Laurent Briollais, Julia A. Knight, (unknown), Yuanyuan Wang, (unknown), Hong Li, (unknown), Irene L. Andrulis, Hilmi Özçelik	131
15	Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations 2006 ·Human Genomics ·Sevtap Savas, Steffen Schmidt, Hamdi Jarjanazi, Hilmi Özçelik	13
16	Comparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 Mutations 2002 ·Human Mutation ·Irene L. Andrulis, Hoda Anton‐Culver, Jeanne C. Beck, Betsy Bove, Jeff Boyd, Saundra S. Buys, Andrew K. Godwin, John L. Hopper, Frederick W. B. Li, Susan L. Neuhausen, Hilmi Özçelik, David Peel, Regina M. Santella, Melissa C. Southey, Nathalie J. van Orsouw, Deon J. Venter, Jan Vijg, Alice S. Whittemore, (unknown)	58
17	p53 Protein Accumulation in Non-Invasive Lesions Surrounding p53 Mutation Positive Invasive Breast Cancers 2001 ·Breast Cancer Research and Treatment ·Susan J. Done, Nona Arneson, Hilmi Özçelik, Mark Redston, Irene L. Andrulis	26
18	Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. 2000 ·PubMed ·Geeta Lal, Geoffrey Liu, (unknown), Pardeep Kaurah, Hilmi Özçelik, Steven A. Narod, Mark Redston, Steven Gallinger	184
19	Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens 2000 ·Carcinogenesis ·Judd C. Rice, Hilmi Özçelik, (unknown), Irene L. Andrulis, Bernard W. Futscher	177
20	ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancer 1997 ·International Journal of Cancer ·Alan G. Casson, Sylvia M. Wilson, J. Andrea McCart, Frances P. O’Malley, Hilmi Özçelik, Ming‐Sound Tsao, Ann F. Chambers	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact